UCL launches Genetics Institute
27 October 2009
Links:
![DNA DNA](https://www.ucl.ac.uk/news/sites/news/files/styles/large_image/public/dna_0.jpg?itok=kB6-3MTE)
The UCL Genetics Institute (UGI) will be holding a public seminar to mark its launch on 11 November.
The UGI has been established to provide a focus for research in Genetics at UCL. The vision for the institute is to create a world-leading centre with multi-disciplinary outreach across the campus, which will develop and apply bio-statistical and bio-informatics approaches to clinical and human population genetics.
This will form a platform from which to address the major challenges to the use of genetics in healthcare.
Genetic technologies are in routine use at UCL in fundamental and applied research in plant, animal and human studies, and the major UGI remit is to develop and apply bio-statistical and bio-informatics approaches to clinical and human population genetics. This will be vital for the translation of genetic science into understanding human health and the pathological mechanisms of human disease, and translating this knowledge into clinically relevant interventions and treatments.
The launch seminar event will include a talk by internationally renowned speaker, Professor John Todd, about diabetes, with further talks from UCL's newly appointed Professor of Biostatistics David Balding, as well as John Hardy (UCL Neurology) who will discuss the advances in the genetic determinants of Alzheimer's disease.
The launch will take place from 2-5pm, 11 November 2009, in the JZ Young Lecture Theatre, Anatomy Building, UCL, followed by a drinks reception with posters displayed in the South Cloisters. To register online or to find out more about this event please go to the links above.
UCL context
The UCL Genetics Institute (UGI) has been established to provide a focus for research in Genetics at UCL. It has a major remit to develop and apply bio-statistical and bio-informatics approaches to clinical and human population genetics. This will be vital for the translation of genetic science into understanding human health and the pathological mechanisms of human disease, and translating this knowledge into
clinically relevant interventions and treatments.